These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 26296336

  • 1. Prevalence and correlates of apathy in myotonic dystrophy type 1.
    Gallais B, Montreuil M, Gargiulo M, Eymard B, Gagnon C, Laberge L.
    BMC Neurol; 2015 Aug 22; 15():148. PubMed ID: 26296336
    [Abstract] [Full Text] [Related]

  • 2. Medication adherence in patients with myotonic dystrophy and facioscapulohumeral muscular dystrophy.
    Fitzgerald BP, Conn KM, Smith J, Walker A, Parkhill AL, Hilbert JE, Luebbe EA, Moxley RT.
    J Neurol; 2016 Dec 22; 263(12):2528-2537. PubMed ID: 27734165
    [Abstract] [Full Text] [Related]

  • 3. Perceived fatigue in myotonic dystrophy type 1: a case-control study.
    Winblad S, Lindberg C.
    BMC Neurol; 2019 Mar 28; 19(1):45. PubMed ID: 30922263
    [Abstract] [Full Text] [Related]

  • 4. Cognitive/personality pattern and triplet expansion size in adult myotonic dystrophy type 1 (DM1): CTG repeats, cognition and personality in DM1.
    Sistiaga A, Urreta I, Jodar M, Cobo AM, Emparanza J, Otaegui D, Poza JJ, Merino JJ, Imaz H, Martí-Massó JF, López de Munain A.
    Psychol Med; 2010 Mar 28; 40(3):487-95. PubMed ID: 19627641
    [Abstract] [Full Text] [Related]

  • 5. Affective symptoms and apathy in myotonic dystrophy type 1 a systematic review and meta-analysis.
    van der Velden BG, Okkersen K, Kessels RP, Groenewoud J, van Engelen B, Knoop H, Raaphorst J.
    J Affect Disord; 2019 May 01; 250():260-269. PubMed ID: 30870776
    [Abstract] [Full Text] [Related]

  • 6. Comparisons of intellectual capacities between mild and classic adult-onset phenotypes of myotonic dystrophy type 1 (DM1).
    Jean S, Richer L, Laberge L, Mathieu J.
    Orphanet J Rare Dis; 2014 Nov 26; 9():186. PubMed ID: 25424323
    [Abstract] [Full Text] [Related]

  • 7. Participation and the Role of Neuropsychological Functioning in Myotonic Dystrophy Type 1.
    Van Heugten C, Meuleman S, Hellebrekers D, Kruitwagen-van Reenen E, Visser-Meily J.
    J Neuromuscul Dis; 2018 Nov 26; 5(2):205-214. PubMed ID: 29865086
    [Abstract] [Full Text] [Related]

  • 8. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I.
    Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G.
    Acta Neurol Scand; 2007 Apr 26; 115(4):265-70. PubMed ID: 17376125
    [Abstract] [Full Text] [Related]

  • 9. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I.
    Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G.
    Eur Neurol; 2006 Apr 26; 56(1):24-30. PubMed ID: 16914927
    [Abstract] [Full Text] [Related]

  • 10. Cognition and event-related potentials in adult-onset non-demented myotonic dystrophy type 1.
    Tanaka H, Arai M, Harada M, Hozumi A, Hirata K.
    Clin Neurophysiol; 2012 Feb 26; 123(2):261-9. PubMed ID: 21741303
    [Abstract] [Full Text] [Related]

  • 11. Depression in Myotonic Dystrophy type 1: clinical and neuronal correlates.
    Winblad S, Jensen C, Månsson JE, Samuelsson L, Lindberg C.
    Behav Brain Funct; 2010 May 19; 6():25. PubMed ID: 20482818
    [Abstract] [Full Text] [Related]

  • 12. Cognitive behaviour therapy plus aerobic exercise training to increase activity in patients with myotonic dystrophy type 1 (DM1) compared to usual care (OPTIMISTIC): study protocol for randomised controlled trial.
    van Engelen B, OPTIMISTIC Consortium.
    Trials; 2015 May 23; 16():224. PubMed ID: 26002596
    [Abstract] [Full Text] [Related]

  • 13. Scapular dyskinesis in myotonic dystrophy type 1: clinical characteristics and genetic investigations.
    Voermans NC, van der Bilt RC, IJspeert J, Hogrel JY, Jeanpierre M, Behin A, Laforet P, Stojkovic T, van Engelen BG, Padberg GW, Sacconi S, Lemmers RJLF, van der Maarel SM, Eymard B, Bassez G.
    J Neurol; 2019 Dec 23; 266(12):2987-2996. PubMed ID: 31471688
    [Abstract] [Full Text] [Related]

  • 14. Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.
    Kalkman JS, Schillings ML, van der Werf SP, Padberg GW, Zwarts MJ, van Engelen BG, Bleijenberg G.
    J Neurol Neurosurg Psychiatry; 2005 Oct 23; 76(10):1406-9. PubMed ID: 16170086
    [Abstract] [Full Text] [Related]

  • 15. Apathy/depression, but not subjective fatigue, is related with cognitive dysfunction in patients with multiple sclerosis.
    Niino M, Mifune N, Kohriyama T, Mori M, Ohashi T, Kawachi I, Shimizu Y, Fukaura H, Nakashima I, Kusunoki S, Miyamoto K, Yoshida K, Kanda T, Nomura K, Yamamura T, Yoshii F, Kira J, Nakane S, Yokoyama K, Matsui M, Miyazaki Y, Kikuchi S.
    BMC Neurol; 2014 Jan 06; 14():3. PubMed ID: 24393373
    [Abstract] [Full Text] [Related]

  • 16. Reliability of the Apathy Evaluation Scale in Myotonic Dystrophy Type 1.
    Gallais B, Gagnon C, Côté I, Forgues G, Laberge L.
    J Neuromuscul Dis; 2018 Jan 06; 5(1):39-46. PubMed ID: 29278897
    [Abstract] [Full Text] [Related]

  • 17. Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.
    Fujino H, Shingaki H, Suwazono S, Ueda Y, Wada C, Nakayama T, Takahashi MP, Imura O, Matsumura T.
    Muscle Nerve; 2018 May 06; 57(5):742-748. PubMed ID: 29193182
    [Abstract] [Full Text] [Related]

  • 18. The development of a model of fatigue in neuromuscular disorders: a longitudinal study.
    Kalkman JS, Schillings ML, Zwarts MJ, van Engelen BG, Bleijenberg G.
    J Psychosom Res; 2007 May 06; 62(5):571-9. PubMed ID: 17467412
    [Abstract] [Full Text] [Related]

  • 19. Disease burden of myotonic dystrophy type 1.
    Landfeldt E, Nikolenko N, Jimenez-Moreno C, Cumming S, Monckton DG, Gorman G, Turner C, Lochmüller H.
    J Neurol; 2019 Apr 06; 266(4):998-1006. PubMed ID: 30788616
    [Abstract] [Full Text] [Related]

  • 20. Influence of multisystemic affection on health-related quality of life in patients with myotonic dystrophy type 1.
    Peric S, Stojanovic VR, Basta I, Peric M, Milicev M, Pavlovic S, Lavrnic D.
    Clin Neurol Neurosurg; 2013 Mar 06; 115(3):270-5. PubMed ID: 22695270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.